ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000228022.1	ABT-263 (navitoclax)	Lymphoid neoplasm diffuse large B-cell lymphoma	0.043175709	Resistant
ENSG00000228022.1	ABT-263 (navitoclax)	Brain lower grade glioma	0.030775966	Resistant